Boocock D.J., Faust G.E., Patel K.R., Schinas A.M., Brown V.A., Ducharme M.P., Booth T.D., Crowell J.A., Perloff M., Gescher A.J., Steward W.P., Brenner D.E. (2007) Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent. Cancer Epidemiol Biomarkers Prev 16:1246-52 PubMed (17548692)

Abbreviation: BOOCOCK 2007_01

Pubmed ID: 17548692

Metabolism

This publication was used in 4 intervention studies.

Source Metabolite Biofluid Organism
Resveratrol Resveratrol plasma human Pharmacokinetics
Resveratrol Resveratrol 3-sulfate plasma human Pharmacokinetics
Resveratrol Resveratrol urine human Pharmacokinetics
Resveratrol Resveratrol 3-sulfate urine human Pharmacokinetics
Resveratrol Resveratrol plasma human Pharmacokinetics
Resveratrol Resveratrol 3-sulfate plasma human Pharmacokinetics
Resveratrol Resveratrol urine human Pharmacokinetics
Resveratrol Resveratrol 3-sulfate urine human Pharmacokinetics
Resveratrol Resveratrol plasma human Pharmacokinetics
Resveratrol Resveratrol 3-sulfate plasma human Pharmacokinetics
Resveratrol Resveratrol urine human Pharmacokinetics
Resveratrol Resveratrol 3-sulfate urine human Pharmacokinetics
Resveratrol Resveratrol plasma human Pharmacokinetics
Resveratrol Resveratrol 3-sulfate plasma human Pharmacokinetics
Resveratrol Resveratrol urine human Pharmacokinetics
Resveratrol Resveratrol 3-sulfate urine human Pharmacokinetics